Guest post by SAMA, a resource group for women and health.
As the clamor dies down, of news reports celebrating the ‘miracle of science’ that made the arrival of Aamir Khan and Kiran Rao’s baby boy possible, it would serve to look more closely at commercial surrogacy in India. Estimated to be a multi-million dollar industry, Assisted Reproductive Technologies (ARTs, through which surrogacies are conducted) are a recent and fast-growing addition to India’s medical market and medical tourism sector. Their unregulated proliferation over the last few years has raised serious issues of safety, ethical practice, costs, and rights. While the proposed Draft Assisted Reproductive Technologies (Regulation) Bill & Rules-2010 is a long-awaited step towards regulation, several clauses, especially concerning commercial surrogacy, leave much to be desired.
Continue reading The Regulation of Surrogacy in India – Questions and Concerns: SAMA